β2-adrenergic receptor gene expression as a prognostic and predictive biomarker in HER2-positive early-stage breast cancer patients enrolled in the NCCTG-N9831 (Alliance) trial
      Google Scholar   
Citation:
Annals of Oncology vol 31 (Supplement 4) S310
Meeting Instance:
ESMO 2020
Year:
2020
Type:
Abstract
Sub type:
Poster General
Funding:
NCTN
Endpoint:
Secondary-not-in-original
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
epub
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Parents:
None
Children:
3323   3713  
Program:
OGC
Primary Committee:
Breast
Sec. Committees:
   
Pharmas:
Genentech, Genomic Health  
Grants:
: U10CA180821, U10CA180882, U24CA196171  
Corr. Author:
 
Authors:
                         
Networks:
 
Study
NCCTG-N9831
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:
3
Keywords: